Valuation (62%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 9.00 | N/A |
| PEG Ratio (TTM) | -0.86 | N/A |
| P/S Ratio (TTM) | 2.39 | N/A |
| P/B Ratio (TTM) | 2.81 | N/A |
| P/FCF Ratio (TTM) | -16.27 | N/A |
| Price to 5YR AVG Earnings Ratio | 31.66 | N/A |
| Price to 5YR AVG FCF Ratio | 15.22 | N/A |
Profitability (60%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 2.22% | N/A |
| ROE (TTM) | 31.63% | N/A |
| Net Profit Margin (TTM) | 26.90% | N/A |
| ROIC 5YR AVG | 35.06% | N/A |
Growth (62%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 126.90% | 50.12% | 27.19% |
| Revenue | 10.52% | 14.36% | 2.66% |
| Net Income | 103.69% | 34.23% | 13.41% |
| Cash Flow | -49.34% | -303.41% | -759.50% |
Health (21%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | N/A | N/A |
| Quick Ratio (TTM) | N/A | N/A |
| D/E Ratio (TTM) | 2.83 | N/A |
| Interest Coverage (TTM) | 1.15 | N/A |
| Piotroski F-Score | 5 | N/A |
| Altman Z-Score | 0.88 | N/A |
| LTL to 5YR AVG FCF | 13.45 | N/A |
| Shares Outstanding Growth 5YR AVG | -11.66% | N/A |